Lafayette Investments’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$419K Hold
835
0.08% 116
2026
Q1
$410K Hold
835
0.08% 109
2025
Q4
$484K Sell
835
-100
-11% -$56.5K 0.09% 105
2025
Q3
$453K Buy
935
+8
+0.9% +$3.72K 0.09% 101
2025
Q2
$376K Buy
927
+22
+2% +$9.2K 0.08% 112
2025
Q1
$450K Buy
905
+75
+9% +$40.6K 0.1% 97
2024
Q4
$432K Hold
830
0.09% 96
2024
Q3
$513K Hold
830
0.11% 86
2024
Q2
$459K Buy
830
+17
+2% +$9.74K 0.1% 88
2024
Q1
$473K Sell
813
-12
-1% -$6.73K 0.11% 87
2023
Q4
$438K Hold
825
0.11% 87
2023
Q3
$418K Hold
825
0.11% 87
2023
Q2
$430K Hold
825
0.11% 86
2023
Q1
$476K Hold
825
0.13% 81
2022
Q4
$454K Hold
825
0.13% 82
2022
Q3
$418K Hold
825
0.13% 81
2022
Q2
$448K Sell
825
-300
-27% -$165K 0.13% 82
2022
Q1
$664K Hold
1,125
0.16% 70
2021
Q4
$751K Hold
1,125
0.19% 69
2021
Q3
$643K Hold
1,125
0.17% 71
2021
Q2
$568K Buy
+1,125
New +$531K 0.15% 78

Other funds holding TMO

Lafayette Investments's TMO Position: Q2 2026 in Review

Lafayette Investments held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 835 shares worth $419K. The position accounts for 0.08% of the portfolio, ranked #116.

Lafayette Investments first reported a position in TMO in Q2 2021 and has held it in 21 quarters since. The position peaked at $751K in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Lafayette Investments held 835 shares of Thermo Fisher Scientific worth $419K as of Q2 2026.
  • Lafayette Investments left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.08% of Lafayette Investments's portfolio in Q2 2026, its #116 holding.
  • Lafayette Investments first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 21 quarters since.
  • Lafayette Investments's Thermo Fisher Scientific position peaked at $751K in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Lafayette Investments's 13F filing for Q2 2026, filed 11 Aug 2026.